Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 2
2004 4
2005 4
2006 4
2007 9
2008 9
2009 11
2010 7
2011 9
2012 12
2013 7
2014 2
2015 3
2016 2
2017 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

73 results

Results by year

Filters applied: . Clear all
Page 1
Delivery of siRNA targeting tumor metabolism using non-covalent PEGylated chitosan nanoparticles: Identification of an optimal combination of ligand structure, linker and grafting method.
Corbet C, Ragelle H, Pourcelle V, Vanvarenberg K, Marchand-Brynaert J, Préat V, Feron O. Corbet C, et al. Among authors: marchand brynaert j. J Control Release. 2016 Feb 10;223:53-63. doi: 10.1016/j.jconrel.2015.12.020. Epub 2015 Dec 14. J Control Release. 2016. PMID: 26699426
Intracellular siRNA delivery dynamics of integrin-targeted, PEGylated chitosan-poly(ethylene imine) hybrid nanoparticles: A mechanistic insight.
Ragelle H, Colombo S, Pourcelle V, Vanvarenberg K, Vandermeulen G, Bouzin C, Marchand-Brynaert J, Feron O, Foged C, Préat V. Ragelle H, et al. Among authors: marchand brynaert j. J Control Release. 2015 Aug 10;211:1-9. doi: 10.1016/j.jconrel.2015.05.274. Epub 2015 May 16. J Control Release. 2015. PMID: 25989603
Self-assembling doxorubicin-tocopherol succinate prodrug as a new drug delivery system: synthesis, characterization, and in vitro and in vivo anticancer activity.
Duhem N, Danhier F, Pourcelle V, Schumers JM, Bertrand O, Leduff CS, Hoeppener S, Schubert US, Gohy JF, Marchand-Brynaert J, Préat V. Duhem N, et al. Among authors: marchand brynaert j. Bioconjug Chem. 2014 Jan 15;25(1):72-81. doi: 10.1021/bc400326y. Epub 2013 Dec 23. Bioconjug Chem. 2014. PMID: 24328289
(S)-1-(Pent-4'-enoyl)-4-(hydroxymethyl)-azetidin-2-one derivatives as inhibitors of human fatty acid amide hydrolase (hFAAH): synthesis, biological evaluation and molecular modelling.
Caruano J, Feledziak M, Labar G, Michaux C, Perpète EA, Muccioli GG, Robiette R, Marchand-Brynaert J. Caruano J, et al. Among authors: marchand brynaert j. J Enzyme Inhib Med Chem. 2014 Oct;29(5):654-62. doi: 10.3109/14756366.2013.837900. Epub 2013 Oct 9. J Enzyme Inhib Med Chem. 2014. PMID: 24102523
Targeted nanoparticles with novel non-peptidic ligands for oral delivery.
des Rieux A, Pourcelle V, Cani PD, Marchand-Brynaert J, Préat V. des Rieux A, et al. Among authors: marchand brynaert j. Adv Drug Deliv Rev. 2013 Jun 15;65(6):833-44. doi: 10.1016/j.addr.2013.01.002. Epub 2013 Feb 20. Adv Drug Deliv Rev. 2013. PMID: 23454185 Review.
73 results